Chemie und Pharma

Trends and challenges for life sciences companies in the new reality

141 views
05.01.2021. agility, artificial intelligence, collaboration models, connected enterprise, Covid-19, customer experience, digitalization, enterprise models, health, life science companies, life sciences, medicine, new reality, patient, patient centricity, pharmacenticals, R&D, research, supply chain, technology, therapy, transformation

Life sciences companies have maneuvered quite well through the Covid-19 pandemic. In the new reality it will be relevant, that the companies leverage their increased societal importance to develop innovative drugs at affordable prices and to become more customer-oriented. Thomas Hillek, Head of Life Sciences & Chemicals at KPMG in Germany, explains which four overarching trends influence the new reality of life sciences companies and highlights possible actions.